Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NRIX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
NRIX
Nurix Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
NRIX
Nurix Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
NRIX
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±17.9%
▼
−0.14%
×0.01
Q2 FY26
±16.5%
▼
−6.60%
×0.40
Apr 8 '26
±25.7%
▼
−4.59%
×0.18
Q1 FY26
±17.3%
▼
−1.57%
×0.09
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
= implied
NRIX realized, solid
LLY realized, hatched
One scale, both sides: full bar = 26%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
NRIX
Nurix Therapeutics, Inc.
Change
25.97
▲
+1.03%
Mkt cap
$2.8B
Revenue
$673M
Q3 FY26
Revenue
$84M
FY25
LLY
ELI Lilly & Co
Change
1,421.81
▲
+0.77%
Regular session
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 3 '26
NRIX
Nurix Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
25.97
▲
+1.03%
Price
1,421.81
▲
+0.77%
$2.8B
Mkt cap
$1.3T
Q3 FY26
$673M
Revenue
$24.4B
Q3 FY26
FY25
$84M
Revenue
$65.2B
FY25
Change
Change
NRIX
25.97
▲
+1.03%
vs
LLY
1,421.81
▲
+0.77%
Regular session
Nov 3 '26